No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 4 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Cellyan Biotechnology Co., Ltd (HKPD) stock was $0.10 as of Oct 6, 2026, 12:22 PM EDT, down 2.61% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -91.5%
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management.
Medical - Distribution · Hong Kong
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
$6.30M
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1HKPD | $1.11M | $0.10 | -2.61% | -91.48% | N/A | N/A | N/A |
| 2IMCC | $1.15M | $1.90 | -2.06% | -96.70% | -80.08% | N/A | vs HKPD |
| 3CMND | $1.06M | $5.70 | -5.00% | -99.81% | N/A | N/A | vs HKPD |
| 4ASBP | $1.04M | $9.00 | +1.35% | -98.04% | N/A | N/A | vs HKPD |
| 5PPCB | $1.18M | $0.52 | +4.02% | N/A | N/A | N/A | vs HKPD |
| 6JUNS | $1.24M | $2.55 | +5.37% | -97.98% | N/A | N/A | vs HKPD |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$0.10
High
N/A
